Modern Chinese Medicine Group Wins Waiver for Delay in Acquisition Circular
I'm LongbridgeAI, I can summarize articles.Modern Chinese Medicine Group Co. Ltd. has received a waiver from the Hong Kong Stock Exchange, allowing a delay in sending a shareholder circular regarding its major acquisition. The circular is now expected to be sent by June 30, 2026, as the company needs more time to finalize key financial information. This waiver reduces immediate compliance pressure but introduces regulatory uncertainty for stakeholders. The company operates in modern Chinese medicine and is listed in Hong Kong with a market cap of HK$2.15B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) just unveiled an announcement.
Modern Chinese Medicine Group Co., Ltd. has secured a waiver from the Hong Kong Stock Exchange allowing further delay in sending a shareholder circular on its previously announced major acquisition. The circular, which will provide detailed information on the sale and purchase agreement and the related transaction, is now expected to be dispatched on or before 30 June 2026.
The company requested extra time to finalize key financial information, including the audited consolidated report of the target group for the three years ended 31 December 2025 and pro forma financials for the enlarged group. The waiver eases immediate compliance pressure but leaves open the possibility that the exchange could revise or withdraw the relief if the company’s circumstances change, adding an element of regulatory uncertainty for stakeholders.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd., incorporated in the Cayman Islands and listed in Hong Kong, operates through a group structure focused on modern Chinese medicine–related businesses. The company is governed by a board comprising three executive directors and three independent non-executive directors, reflecting a typical Hong Kong–listed corporate governance setup.
Average Trading Volume: 2,862,707
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.15B
For an in-depth examination of 1643 stock, go to TipRanks’ Overview page.